Head-to-Head Review: Chemours (NYSE:CC) and BioLargo (NASDAQ:BLGO)

BioLargo (NASDAQ:BLGO – Get Free Report) and Chemours (NYSE:CC ​​- Get Free Report) are both construction companies, but which is the superior investment? We’ll compare the two companies based on earnings strength, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

Rating and Earnings

This table compares BioLargo and Chemours’ gross revenue, earnings per share (EPS) and valuation.

BioLargo has higher revenue, but lower revenue than Chemours. Chemours is trading at a lower price-to-earnings ratio than BioLargo, indicating that it is currently the more affordable of the two stocks.

return

This table compares BioLargo and Chemours’ net margins, return on equity, and return on assets.

Volatility and risk

BioLargo has a beta of 0.2, which means its stock price is 80% less volatile than the S&P 500. In comparison, Chemours has a beta of 1.75, which means its stock price is 75% more volatile than the S&P 500.

Institutional and insider ownership

0.0% of BioLargo shares are held by institutional investors. Comparatively, 76.3% of Chemours shares are held by institutional investors. 20.3% of BioLargo shares are owned by company insiders. Comparatively, 0.5% of Chemours shares are held by company insiders. Strong institutional ownership is an indication that big money managers, endowments and hedge funds believe the stock is poised for long-term growth.

Analyst ratings

This is a summary of recent ratings and price targets for BioLargo and Chemours, as reported by MarketBeat.

Chemours has a consensus target price of $26.75, indicating a potential upside of 43.05%. Given Chemours’ higher possible upside, analysts plainly believe Chemours is more favorable than BioLargo.

Summary

Chemours beats BioLargo on 8 of the 13 factors compared between the two stocks.

About BioLargo

(Get a free report)

BioLargo, Inc. invents, develops and commercializes various platform technologies. Its technologies solve challenging environmental problems, including polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compound control, air quality control, infection control and countless environmental remediations. The company offers full environmental engineering services. BioLargo, Inc. was founded in 1991 and is headquartered in Westminster, California.

About Chemours

(Get a free report)

Chemours supplies performance chemicals to North America, Asia Pacific, Europe, the Middle East, Africa and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions and Advanced Performance Materials. The Titanium Technologies segment offers TiO2 pigment under the Ti-Pure brand to provide whiteness, brightness, opacity, durability, efficiency and protection in various applications such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinyl chloride, laminated paper used. for furniture and building materials, laminated paper and laminated board used for packaging. The Thermal & Specialized Solutions segment offers refrigerants, thermal management solutions, propellants, foam blowing agents and specialty solvents. The Advanced Performance Materials segment’s product portfolio includes various industrial resins, specialty products, membranes and coatings for electronics, communications, transportation, wire and cable, energy, oil and gas, and medical and other applications under Eflon, Viton, Krytox, and Nafion brands. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. Chemours was founded in 2014 and is headquartered in Wilmington, Delaware.

Get news and reviews for BioLargo Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for BioLargo and related companies with MarketBeat.com’s FREE daily email newsletter.